SEC Form 4 · Insider disclosures

Insider Trading Tracker

Who bought, who sold, and the disclosed plans and ownership context behind recent SEC Form 4 filings.

Updates are delayed; the last verified disclosures remain available.

Purchase rows312
Sale rows1,613
Purchase value (USD)US$469.72M
Sale value (USD)US$1.44B

Last 10 days of filings·Updated Oct 23, 3:53 AM ET

Recent company disclosures

429 companies · 1,925 rows
WSM

WILLIAMS SONOMA INC

Total value ≈ US$200.2K

2 transaction rows · 1 filings

Finucane Anne A.

Sale
Director disclosed sale of 780 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 9.42K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$196.65K

Finucane Anne A.

Sale
Director disclosed sale of 14 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 9.4K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$3.54K
COHU

COHU INC

Total value ≈ US$55.31K

1 transaction rows · 1 filings

BOHRSON CHRISTOPHER

Sale
Officer disclosed sale of 1,000 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 0.63% of prior direct holdings; approximately 158K shares remain

Calculated transaction value approximately US$55.31K
MDT

Medtronic plc

Total value ≈ US$5.75M

2 transaction rows · 2 filings

Marinaro Michael

Sale
Officer disclosed sale of 10,420 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 8.95% of prior direct holdings; approximately 106K shares remain

Calculated transaction value approximately US$1M

Martha Geoffrey

Sale
CEO / Director disclosed sale of 50,000 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 15.25% of prior direct holdings; approximately 278K shares remain

Calculated transaction value approximately US$4.75M
PRIM

Primoris Services Corp

Total value ≈ US$1.72K

1 transaction rows · 1 filings

MCCALLISTER TERRY D

Purchase
Director disclosed purchase of 21.505 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.10%; approximately 21.5K shares afterward

Calculated transaction value approximately US$1.72K
PL

Planet Labs PBC

Total value ≈ US$664.45K

2 transaction rows · 2 filings

Robinson Kristen

Sale
Director disclosed sale of 40,000 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 17.94% of prior indirect holdings; approximately 183K shares remain

Calculated transaction value approximately US$565.56K

Raymond John w

Sale
Director disclosed sale of 6,494 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 17.49% of prior indirect holdings; approximately 30.6K shares remain

Calculated transaction value approximately US$98.89K
SAH

SONIC AUTOMOTIVE INC

Total value ≈ US$752.04K

1 transaction rows · 1 filings

Rusnak Paul P.

Purchase
10% owner disclosed purchase of 12,555 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.24%; approximately 5.18M shares afterward

Calculated transaction value approximately US$752.04K
LIFE

Ethos Technologies Inc.

Total value ≈ US$9.15M

10 transaction rows · 2 filings

Wang Lingke

Sale
Officer / Director disclosed sale of 22,669 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.63M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$853.26K

Wang Lingke

Sale
Officer / Director disclosed sale of 94,864 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$3.65M
Show 8 more transaction rows

Wang Lingke

Sale
Officer / Director disclosed sale of 800 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$31.31K

Colis Peter George

Sale
CEO / Director disclosed sale of 31,900 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.55M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.24M

Colis Peter George

Sale
CEO / Director disclosed sale of 8,100 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$320.6K

Colis Peter George

Sale
CEO / Director disclosed sale of 8,165 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.57M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$307.33K

Colis Peter George

Sale
CEO / Director disclosed sale of 31,435 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.21M

Colis Peter George

Sale
CEO / Director disclosed sale of 400 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$15.65K

Colis Peter George

Sale
CEO / Director disclosed sale of 34,468 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.3M

Colis Peter George

Sale
CEO / Director disclosed sale of 5,532 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.54M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$211.99K
SNPS

SYNOPSYS INC

Total value ≈ US$6.76M

1 transaction rows · 1 filings

Ghazi Sassine

Sale
CEO / Director disclosed sale of 14,604 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 76.9K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$6.76M
MQ

Marqeta, Inc.

Total value ≈ US$23.45K

1 transaction rows · 1 filings

Sumner Crystal

Sale
Officer disclosed sale of 1,250 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 0.74% of prior direct holdings; approximately 168K shares remain

Calculated transaction value approximately US$23.45K
KWY

KINGSWAY Corp

Total value ≈ US$5.04K

2 transaction rows · 2 filings

Fitzgerald John Taylor Maloney

Purchase
CEO / Director disclosed purchase of 357 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.02%; approximately 1.43M shares afterward

Calculated transaction value approximately US$3.48K

Hansen Kent A

Purchase
CFO disclosed purchase of 160 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.11%; approximately 137K shares afterward

Calculated transaction value approximately US$1.56K
N/A

BIP Ventures Evergreen BDC

Total value ≈ US$129K

3 transaction rows · 2 filings

Flickinger Mark

Purchase
Officer / Director disclosed purchase of 1,064 shares

Filing did not check the 10b5-1 plan indicator

Approximately 5.38K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$37.02K

Flickinger Mark

Purchase
Officer / Director disclosed purchase of 1,207 shares

Filing did not check the 10b5-1 plan indicator

Approximately 1.91K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$41.99K
Show 1 more transaction rows

Buffington Mark

Purchase
CEO / Director disclosed purchase of 1,437 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately 7.02%; approximately 21.9K shares afterward

Calculated transaction value approximately US$49.99K
PTCT

PTC THERAPEUTICS, INC.

Total value ≈ US$149.04K

2 transaction rows · 1 filings

SCHMERTZLER MICHAEL

Sale
Director disclosed sale of 2,118 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.29M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$126.06K

SCHMERTZLER MICHAEL

Sale
Director disclosed sale of 382 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.29M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$22.97K
Sources, coverage & updates
SEC filing dates: 2026-10-14 — 2026-10-23 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Oct 23, 3:53 AM ET

Historical dates reconciled; current day provisional

Discovered filings 2,284 · Parsed 2,284 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 9 unavailable, unverified or non-USD amounts are excluded. 743 filings · 691 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗